Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/01/2007EP1813611A1 1-substituted-3- beta-d-glucopyranosylated nitrogenous hetero- cyclic compounds and medicines containing the same
08/01/2007EP1813610A1 Novel pyridonecarboxylic acid derivatives or salts thereof
08/01/2007EP1813609A2 Novel aminopyridine derivatives having selective aurora-a inhibitory effect
08/01/2007EP1813606A1 Amide compound
08/01/2007EP1813603A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
08/01/2007EP1813602A1 Crystal of two-ring heterocyclic sulfonamide compound
08/01/2007EP1813600A1 N-n-acyloxypropyl lysine methyl ester- and n,n-bis(n- acyloxypropyl)lysine methyl ester-type compounds and use thereof as surface-active agents with an antimicrobial activity
08/01/2007EP1813294A1 Adhesion preventive and method of preventing adhesion
08/01/2007EP1813289A1 Medicinal composition for treating cancer or diabetes
08/01/2007EP1813287A1 Type ii cubic liquid crystal composition
08/01/2007EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
08/01/2007EP1813285A1 Preventive or therapeutic agent for neuropathic pain
08/01/2007EP1813284A1 Pharmaceutical composition
08/01/2007EP1813283A1 Remedy for neuropathic pain
08/01/2007EP1813282A1 Remedy for angiospasm accompanying subarachnoid hemorrhage contianing thrombin receptor antagonist as the active ingredient
08/01/2007EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base
08/01/2007EP1813277A1 Dispenser for dispensing two or more substances
08/01/2007EP1813276A1 Tamper resistant dosage forms
08/01/2007EP1813275A1 Lansoprazole orally disintegrating tablets
08/01/2007EP1813274A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition
08/01/2007EP1813273A1 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
08/01/2007EP1813272A1 Veterinary use of a lleuromutilin derivate againts ileitis in swine
08/01/2007EP1813271A1 Preventive/therapeutic agent for visceral pain
08/01/2007EP1813270A1 Hsp90 family protein inhibitors
08/01/2007EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO
08/01/2007EP1813255A1 Stable combination of active agents containing glucose derivates and hydroxycarboxylic acids
08/01/2007EP1813156A1 Packed beverage for lipid combustion promotion
08/01/2007EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases
08/01/2007EP1812597A2 Mammalian genes involved in infection
08/01/2007EP1812596A2 Treatment of cancer and compositions
08/01/2007EP1812455A2 Erythromycin a derivatives as antibacterial agents
08/01/2007EP1812451A2 Compounds and methods of use thereof
08/01/2007EP1812450A2 Tgf-beta inhibitors
08/01/2007EP1812446A1 Pharmaceutical compounds
08/01/2007EP1812445A1 Pharmaceutical compounds
08/01/2007EP1812444A1 Pharmaceutical compounds
08/01/2007EP1812443A2 [3.2.0] heterocyclic compounds and methods of using the same
08/01/2007EP1812442A2 Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
08/01/2007EP1812441A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors
08/01/2007EP1812440A1 PYRAZOLOÝ1,5-a¨PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
08/01/2007EP1812439A2 Kinase inhibitors
08/01/2007EP1812438A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
08/01/2007EP1812436A1 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
08/01/2007EP1812434A2 1,7-naphthyridines as pde4 inhibitors
08/01/2007EP1812433A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
08/01/2007EP1812431A1 4-(pyrazine-2-yl)-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
08/01/2007EP1812430A1 Substituted phenylaminothiazoles and use thereof
08/01/2007EP1812429A2 Substituted 2h-1,3-benzoxazin-4(3h)-ones
08/01/2007EP1812428A2 Zolmitriptan crystal forms
08/01/2007EP1812426A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
08/01/2007EP1812425A2 C-fms kinase inhibitors
08/01/2007EP1812424A2 Kinase inhibitors
08/01/2007EP1812422A1 Polymorph form of irbesartan
08/01/2007EP1812420A1 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
08/01/2007EP1812419A2 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
08/01/2007EP1812418A1 Dibenzosuberone derivatives
08/01/2007EP1812417A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators
08/01/2007EP1812416A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor
08/01/2007EP1812412A1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same
08/01/2007EP1812409A1 Aminoquinazolines compounds
08/01/2007EP1812408A2 Pyridazine compounds, compositions and methods
08/01/2007EP1812407A2 Novel compounds of substituted and unsubstituted adamantyl amides
08/01/2007EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
08/01/2007EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs
08/01/2007EP1812404A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
08/01/2007EP1812403A2 Pyrazolobenzamides and derivatives as factor xa inhibitors
08/01/2007EP1812398A1 Compounds having activity at nk3 receptor and uses thereof in medicine
08/01/2007EP1812390A2 Methylphenidate analogs and methods of use thereof
08/01/2007EP1812389A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/01/2007EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease
08/01/2007EP1812387A1 2,3,4-substituted cyclopentanones as therapeutic agents
08/01/2007EP1812383A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
08/01/2007EP1812377A1 Aminated polyamines
08/01/2007EP1812374A1 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
08/01/2007EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
08/01/2007EP1812114A2 Ecteinascidin compounds as anti-inflammatory agents
08/01/2007EP1812113A1 Pyrimidine compounds as histamine modulators
08/01/2007EP1812112A2 Chemical compounds
08/01/2007EP1812075A1 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
08/01/2007EP1812073A1 Delivery system for topically applied compounds
08/01/2007EP1812072A2 Benzothiazole formulations and use thereof
08/01/2007EP1812071A2 Compounds for nonsense suppression, use of these compounds for the manufacture of a medicament for treating somatic mutation-related diseases
08/01/2007EP1812070A1 Treatment of restless legs syndrome
08/01/2007EP1812069A2 Method for treating hiv infection through co-administration of tipranavir and etravirine
08/01/2007EP1812066A2 Staphylococcus aureus isd protein-based anti-infectives
08/01/2007EP1812049A2 Kallikrein inhibitors and uses thereof
08/01/2007EP1812041A2 Compositions and methods for modulating pgc-1 to treat lipid-related diseases and disorders
08/01/2007EP1812040A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound
08/01/2007EP1812028A2 Herbal composition phy906 and its use in chemotherapy
08/01/2007EP1812024A1 Bacterial compositions for prevention or treatment of atherosclerotic disorders
08/01/2007EP1812022A2 Stand-alone film and methods for making the same
08/01/2007EP1812021A2 Once a day formulation for phosphate binders
08/01/2007EP1812020A1 Presbyopia treatment by lens alteration
08/01/2007EP1812019A1 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
08/01/2007EP1812018A1 Treatment and prevention of multi-drug resistance
08/01/2007EP1812017A2 Ophthamological drugs
08/01/2007EP1812016A2 HIGHLY BRANCHED HK PEPTIDES AS EFFECTIVE CARRIERS OF siRNA
08/01/2007EP1812015A2 Methods for inhibition of nkt cells
08/01/2007EP1812013A1 Compositions for treating and/or preventing diseases characterized by the presence of the metal ions
08/01/2007EP1812012A2 Protein tyrosine phosphatase inhibitors and methods of use thereof
1 ... 3645 3646 3647 3648 3649 3650 3651 3652 3653 3654 3655 3656 3657 3658 3659 3660 3661 3662 3663 3664 3665 ... 7860